Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests

BMC Health Services Research
Mogens VybergVolker Teichgräber

Abstract

Treatment for patients with breast cancer (BC) is guided by human epidermal growth factor receptor 2 (HER2) status. The patient's HER2 status is assessed using US Food and Drug Administration-approved in vitro diagnostic (IVD) immunohistochemical (IHC) tests and laboratory-developed IVD tests. We analysed HER2 testing accuracy using data from the Nordic Immunohistochemistry Quality Control (NordiQC) HER2 IHC programme; results were used in an economic BC treatment model. Data were obtained from NordiQC HER2 BC surveys performed from 2008 to 2012. False-negative (FN) and false-positive (FP) rates for approved and laboratory-developed IVDs were used to estimate direct costs, loss of survival, productivity benefit and quality-adjusted life-years. In the absence of consistent and accessible clinical and economic data from countries participating in the NordiQC programme, United States productivity data, healthcare costs and patient numbers were used as a surrogate in order to estimate the potential impact of selecting an approved or laboratory-developed IVDs. In total, 1703 tests were performed. Pooled FN rates were 11% for approved IVDs and 25% for laboratory-developed IVDs; FP rates were 0% and 5%, respectively. Using these FP an...Continue Reading

References

Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Jan 24, 2007·Breast Cancer Research : BCR·Lisa K DunnwaldChristopher I Li
May 9, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Nandini DendukuriJames Brophy
Oct 30, 2008·Virchows Archiv : an International Journal of Pathology·Reinhard von WasielewskiHans Kreipe
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Oct 14, 2011·The New England Journal of Medicine·Dennis SlamonUNKNOWN Breast Cancer International Research Group
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Aug 22, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Manijeh MahdaviMohammad Rabbani
Mar 13, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungKang Hyun Lee

❮ Previous
Next ❯

Software Mentioned

NordiQC

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Louis P GarrisonMelissa Brammer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
P BirnerAustrian Breast & Colorectal Cancer Study Group
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Yoriko Yamashita-KashimaNaoki Harada
© 2021 Meta ULC. All rights reserved